Jeffrey Bluestone Talks About Immune Rejection of Stem Cell-Based Therapies

Jack Hubbard

Any cells derived from embryonic stem cells that are transplanted as a therapy will likely be rejected by the immune system much like a transplanted heart or liver. Dr. Jeffrey Bluestone has been studying ways of achieving transplantation with little or no drugs. He is the A.W. & Mary Margaret Clausen Distinguished Professor of Medicine, Pathology, Microbiology & Immunology, Interim Associate Vice Chancellor, Research, Director of the Immune Tolerance Network, and is a member of the UCSF Institute for Regeneration Medicine.